Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -1,148 | -973 | N/A | N/A |
| Depreciation Amortization | 2 | 1 | N/A | N/A |
| Accounts receivable | 59 | -36 | N/A | N/A |
| Other Working Capital | 166 | 182 | N/A | N/A |
| Other Operating Activity | 517 | 36 | 0 | 0 |
| Operating Cash Flow | $-405 | $-790 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | -7 | N/A | N/A |
| Investing Cash Flow | $N/A | $-7 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | 1,050 | N/A | N/A |
| Financing Cash Flow | $N/A | $1,050 | $N/A | $N/A |
| Exchange Rate Effect | 62 | 19 | N/A | N/A |
| Beginning Cash Position | 734 | 462 | N/A | N/A |
| End Cash Position | 391 | 734 | N/A | N/A |
| Net Cash Flow | $-343 | $272 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -405 | -790 | N/A | N/A |
| Capital Expenditure | N/A | -7 | N/A | N/A |
| Free Cash Flow | -405 | -797 | 0 | 0 |